| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.180 | 19.440 | 18.914 | 16.352 | 13.571 | 11.921 | 15.509 | 16.411 | 23.384 | 21.159 |
| Total Income - EUR | 8.186 | 19.542 | 18.968 | 16.413 | 13.673 | 11.948 | 15.533 | 16.583 | 23.480 | 21.159 |
| Total Expenses - EUR | 6.786 | 16.556 | 17.528 | 15.578 | 12.577 | 11.517 | 16.498 | 18.172 | 21.574 | 19.957 |
| Gross Profit/Loss - EUR | 1.400 | 2.986 | 1.440 | 835 | 1.096 | 431 | -965 | -1.589 | 1.906 | 1.202 |
| Net Profit/Loss - EUR | 1.155 | 2.403 | 872 | 344 | 696 | 208 | -1.267 | -2.075 | 1.608 | 1.033 |
| Employees | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Bio-Market Lux S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 882 | 507 | 146 | 0 | 9.301 | 7.217 | 5.089 | 2.967 |
| Current Assets | 3.537 | 7.414 | 5.663 | 5.392 | 6.761 | 6.119 | 3.390 | 4.003 | 5.089 | 6.582 |
| Inventories | 3.362 | 7.286 | 5.400 | 5.111 | 6.531 | 5.325 | 3.300 | 3.855 | 2.739 | 3.386 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 175 | 129 | 264 | 281 | 230 | 793 | 91 | 149 | 2.350 | 3.196 |
| Shareholders Funds | 1.209 | 3.600 | 4.805 | 5.061 | 5.659 | 5.760 | 4.366 | 2.304 | 3.905 | 4.916 |
| Social Capital | 45 | 45 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 2.328 | 3.815 | 1.740 | 838 | 1.248 | 358 | 8.325 | 8.916 | 6.273 | 4.632 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4778
|
|||||||||
Comments - Bio-Market Lux S.r.l.